Davide
Bello
Pfizer (United States)
Nueva York, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Pfizer (United States) (1)
2021
-
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis
Journal of Medicinal Chemistry, Vol. 64, Núm. 21, pp. 16159-16176